Quantum Insights Launches AURA AI Platform for Clinical Research Labs

Quantum Insights Launches AURA AI Platform for Clinical Research Labs

FOR IMMEDIATE RELEASE — Berlin, Germany — May 14, 2026

Quantum Insights GmbH, a Berlin-based health-tech company, today announced AURA, an AI-powered analytics platform designed for clinical research laboratories. AURA cuts time-to-insight on multi-omics datasets by up to 70% while keeping patient data on-premises.

Lab prototype on the test bench.

A New Standard for Lab Analytics

Built on a privacy-preserving inference engine, AURA helps research labs correlate genomic, proteomic, and imaging data without moving samples to the cloud. The platform integrates with existing LIMS and ELN systems through a documented API.

CEO Maria Chen unveils the device.

"AURA is the platform our research partners told us they needed," said Maria Chen, CEO of Quantum Insights. "We worked with twelve labs across Europe to make sure every workflow we ship maps to a real bench-side problem."

Production and Availability

Manufacturing is anchored at the company's expanded Berlin facility, with secondary assembly in Reykjavík. AURA is available immediately to qualifying labs through a tiered subscription, starting at €1,490 per month per seat.

Production line at the Berlin facility.

Field deployment near Reykjavík.

Customer Momentum

Since opening early access in February 2026, Quantum Insights has onboarded 38 research institutions and processed more than 1.2 million de-identified samples. Q1 customer growth was 4.3x year-over-year.

Q1 2026 customer growth chart.

Learn more about AURA at the AURA product page, read the 2026 technical whitepaper, browse the developer documentation, review our security posture, and view the press kit, or visit our contact page for partnership inquiries.

About Quantum Insights

Founded in 2021, Quantum Insights GmbH builds privacy-preserving AI infrastructure for life-sciences research. The company is backed by Volker Capital and EU Horizon grants.